Literature DB >> 26622541

AKT plays a crucial role in gastric cancer.

Takamitsu Sasaki1, Yuichi Yamashita1, Hiroki Kuniyasu2.   

Abstract

The AKT protein is involved in the phosphatidylinositol-3 kinase signaling pathway and is a vital regulator of survival, proliferation and differentiation in various types of cells. Helicobacter pylori infection induces epithelial cell proliferation and oxidative stress in chronic gastritis. These alterations lead to telomere shortening, resulting in the activation of telomerase. AKT, in particular, is activated by H. pylori-induced inflammation. AKT then promotes the expression of human telomerase reverse transcriptase, which encodes a catalytic subunit of telomerase, and induces telomerase activity, an essential component of the process of carcinogenesis. AKT activation is increased in gastric mucosa with carcinogenic properties and is associated with the low survival of patients with gastric cancer. The findings of the present study suggest that AKT is pivotal in gastric carcinogenesis and progression.

Entities:  

Keywords:  Helicobacter pylori; chronic gastritis; hTERT; telomerase

Year:  2015        PMID: 26622541      PMCID: PMC4509140          DOI: 10.3892/ol.2015.3260

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  46 in total

Review 1.  The structure and function of telomerase reverse transcriptase.

Authors:  Chantal Autexier; Neal F Lue
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

2.  Ubiquitin ligase MKRN1 modulates telomere length homeostasis through a proteolysis of hTERT.

Authors:  Jun Hyun Kim; Sun-Mi Park; Mi Ran Kang; Sue-Young Oh; Tae H Lee; Mark T Muller; In Kwon Chung
Journal:  Genes Dev       Date:  2005-04-01       Impact factor: 11.361

3.  Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer.

Authors:  Yasutaka Sukawa; Hiroyuki Yamamoto; Katsuhiko Nosho; Hiroaki Kunimoto; Hiromu Suzuki; Yasushi Adachi; Mayumi Nakazawa; Takayuki Nobuoka; Mariko Kawayama; Masashi Mikami; Takashi Matsuno; Tadashi Hasegawa; Koichi Hirata; Kohzoh Imai; Yasuhisa Shinomura
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

Review 4.  The Akt-associated microRNAs.

Authors:  Min Xu; Yin-Yuan Mo
Journal:  Cell Mol Life Sci       Date:  2012-08-31       Impact factor: 9.261

Review 5.  Helicobacter pylori infection and carcinogenesis of the stomach.

Authors:  H Kuniyasu; W Yasui; H Yokozaki; E Tahara
Journal:  Langenbecks Arch Surg       Date:  2000-03       Impact factor: 3.445

6.  Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway.

Authors:  M You; D H Yu; G S Feng
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

7.  Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.

Authors:  Z Liu; Q Li; K Li; L Chen; W Li; M Hou; T Liu; J Yang; C Lindvall; M Björkholm; J Jia; D Xu
Journal:  Oncogene       Date:  2012-10-08       Impact factor: 9.867

Review 8.  Oncogenic mechanisms of the Helicobacter pylori CagA protein.

Authors:  Masanori Hatakeyama
Journal:  Nat Rev Cancer       Date:  2004-09       Impact factor: 60.716

Review 9.  Role of nitrative and oxidative DNA damage in inflammation-related carcinogenesis.

Authors:  Mariko Murata; Raynoo Thanan; Ning Ma; Shosuke Kawanishi
Journal:  J Biomed Biotechnol       Date:  2012-01-26

Review 10.  VEGFA and tumour angiogenesis.

Authors:  L Claesson-Welsh; M Welsh
Journal:  J Intern Med       Date:  2013-02       Impact factor: 8.989

View more
  7 in total

1.  A small sustained increase in NOD1 abundance promotes ligand-independent inflammatory and oncogene transcriptional responses.

Authors:  Leah M Rommereim; Ajay Suresh Akhade; Bhaskar Dutta; Carolyn Hutcheon; Nicolas W Lounsbury; Clifford C Rostomily; Ram Savan; Iain D C Fraser; Ronald N Germain; Naeha Subramanian
Journal:  Sci Signal       Date:  2020-12-08       Impact factor: 8.192

Review 2.  Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review).

Authors:  George Mihai Nitulescu; Denisa Margina; Petras Juzenas; Qian Peng; Octavian Tudorel Olaru; Emmanouil Saloustros; Concettina Fenga; Demetrios Α Spandidos; Massimo Libra; Aristidis M Tsatsakis
Journal:  Int J Oncol       Date:  2015-12-24       Impact factor: 5.650

3.  Rictor Activates Cav 1 Through the Akt Signaling Pathway to Inhibit the Apoptosis of Gastric Cancer Cells.

Authors:  Rui-Zhen Cao; Li Min; Si Liu; Ru-Yue Tian; Hai-Yan Jiang; Juan Liu; Lin-Lin Shao; Rui Cheng; Sheng-Tao Zhu; Shui-Long Guo; Peng Li
Journal:  Front Oncol       Date:  2021-09-01       Impact factor: 6.244

4.  Suppressed Helicobacter pylori-associated gastric tumorigenesis in Fat-1 transgenic mice producing endogenous ω-3 polyunsaturated fatty acids.

Authors:  Young-Min Han; Kyung-Jo Kim; Migyeung Jeong; Jong-Min Park; Eun-Jin Go; Jing X Kang; Sung Pyo Hong; Ki Baik Hahm
Journal:  Oncotarget       Date:  2016-10-11

5.  Relationship between tumour PTEN/Akt/COX-2 expression, inflammatory response and survival in patients with colorectal cancer.

Authors:  Antonia K Roseweir; Arfon G M T Powell; Lindsay Bennett; Hester C Van Wyk; James Park; Donald C McMillan; Paul G Horgan; Joanne Edwards
Journal:  Oncotarget       Date:  2016-10-25

6.  Quinalizarin Induces Apoptosis through Reactive Oxygen Species (ROS)-Mediated Mitogen-Activated Protein Kinase (MAPK) and Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathways in Colorectal Cancer Cells.

Authors:  Ling-Qi Meng; Yue Wang; Ying-Hua Luo; Xian-Ji Piao; Chang Liu; Yue Wang; Yi Zhang; Jia-Ru Wang; Hao Wang; Wan-Ting Xu; Yang Liu; Yi-Qin Wu; Hu-Nan Sun; Ying-Hao Han; Mei-Hua Jin; Gui-Nan Shen; Nan-Zhu Fang; Cheng-Hao Jin
Journal:  Med Sci Monit       Date:  2018-06-03

7.  Establishment of novel long-term cultures from EpCAM positive and negative circulating tumour cells from patients with metastatic gastroesophageal cancer.

Authors:  Daniel Brungs; Elahe Minaei; Ann-Katrin Piper; Jay Perry; Ashleigh Splitt; Martin Carolan; Shantay Ryan; Xiao Juan Wu; Stéphanie Corde; Moeava Tehei; Morteza Aghmesheh; Kara L Vine; Therese M Becker; Marie Ranson
Journal:  Sci Rep       Date:  2020-01-17       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.